CoChat

Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program

Open access

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

Tissue and vessel wall stiffening alters endothelial cell properties and contributes to vascular dysfunction. However, whether extracellular matrix (ECM) stiffness impacts vascular development is not known. Here we show that matrix stiffness controls lymphatic vascular morphogenesis. Atomic force microscopy measurements in mouse embryos reveal that venous lymphatic endothelial cell (LEC) progenitors experience a decrease in substrate stiffness upon migration out of the cardinal vein, which induces a GATA2-dependent transcriptional program required to form the first lymphatic vessels. Transcriptome analysis shows that LECs grown on a soft matrix exhibit increased GATA2 expression and a GATA2-dependent upregulation of genes involved in cell migration and lymphangiogenesis, including VEGFR3. Analyses of mouse models demonstrate a cell-autonomous function of GATA2 in regulating LEC responsiveness to VEGF-C and in controlling LEC migration and sprouting in vivo. Our study thus uncovers a mechanism by which ECM stiffness dictates the migratory behavior of LECs during early lymphatic development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-03959-6

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Venous LEC progenitors experience lower matrix stiffness upon migration out of the cardinal vein. a, b Immunofluorescence of sagittal (a) and transverse (b) vibratome sections of E11 Prox1-GFP embryos using antibodies against PROX1 (magenta), GFP (green, Prox1 reporter) and Collagen I (single channel images in B only). In a, note the round nuclear shape of PROX1+ LECs in the cardinal vein (CV) (arrows) compared to elongated nuclei of the migrating PROX1+ LECs (arrowheads) in the surrounding tissue. In b, aorta (A) and blood capillaries (BC) show higher Collagen I levels compared to CV (arrow) and migrating LECs (arrowheads). c Quantification of Collagen I density in the respective vessel types and avascular tissue in E11 embryos. Data represent mean integrated density values of corrected total cell fluorescence ± s.e.m. (unpaired Student’s t-test) quantified from n = 10 images taken from two embryos. d Immunofluorescence of transverse vibratome sections of E11 wild type embryos using antibodies against Emcn (magenta; marker of venous EC) and LaminB (green, marker of nuclear envelope). Single plane image for LaminB staining is shown as a close-up (grey). Nuclear morphology is distorted in cells outside the CV (arrow), as opposed to a round morphology in cells of the CV vessel wall (arrowhead). e Quantification of nuclear circularity of Emcn+ venous ECs (CV wall) and Emcn− cells of the surrounding tissue (outside CV). Horizontal lines represent mean (n = 30 (CV wall) and n = 34 (outside CV) from two embryos). p value, unpaired Student’s t-test. f Ex vivo AFM measurements (graph on the left) in transverse vibratome sections (image on the right) of E11 Prox1-GFP embryos. Young’s Modulus (kPa) is a measure for the actual tissue stiffness. Horizontal lines represent mean (n = 10 measurements from one embryo (CV) and n = 114 measurements from three embryos (outside CV)). p value, unpaired Student’s t-test. Measurements were done on the dorsal side of the CV (arrow) and the area of LEC migration (boxed area, outside CV). Prox1-GFP+ spinal cord (SC), dorsal root ganglion (DRG) and nerve (N) were used for orientation. Scale bars: 100 µm
Fig. 1 Venous LEC progenitors experience lower matrix stiffness upon migration out of the cardinal vein. a, b Immunofluorescence of sagittal (a) and transverse (b) vibratome sections of E11 Prox1-GFP embryos using antibodies against PROX1 (magenta), GFP (green, Prox1 reporter) and Collagen I (single channel images in B only). In a, note the round nuclear shape of PROX1+ LECs in the cardinal vein (CV) (arrows) compared to elongated nuclei of the migrating PROX1+ LECs (arrowheads) in the surrounding tissue. In b, aorta (A) and blood capillaries (BC) show higher Collagen I levels compared to CV (arrow) and migrating LECs (arrowheads). c Quantification of Collagen I density in the respective vessel types and avascular tissue in E11 embryos. Data represent mean integrated density values of corrected total cell fluorescence ± s.e.m. (unpaired Student’s t-test) quantified from n = 10 images taken from two embryos. d Immunofluorescence of transverse vibratome sections of E11 wild type embryos using antibodies against Emcn (magenta; marker of venous EC) and LaminB (green, marker of nuclear envelope). Single plane image for LaminB staining is shown as a close-up (grey). Nuclear morphology is distorted in cells outside the CV (arrow), as opposed to a round morphology in cells of the CV vessel wall (arrowhead). e Quantification of nuclear circularity of Emcn+ venous ECs (CV wall) and Emcn− cells of the surrounding tissue (outside CV). Horizontal lines represent mean (n = 30 (CV wall) and n = 34 (outside CV) from two embryos). p value, unpaired Student’s t-test. f Ex vivo AFM measurements (graph on the left) in transverse vibratome sections (image on the right) of E11 Prox1-GFP embryos. Young’s Modulus (kPa) is a measure for the actual tissue stiffness. Horizontal lines represent mean (n = 10 measurements from one embryo (CV) and n = 114 measurements from three embryos (outside CV)). p value, unpaired Student’s t-test. Measurements were done on the dorsal side of the CV (arrow) and the area of LEC migration (boxed area, outside CV). Prox1-GFP+ spinal cord (SC), dorsal root ganglion (DRG) and nerve (N) were used for orientation. Scale bars: 100 µmCC BY · PubMed Central
Fig. 2 GATA2 regulation by matrix stiffness in LECs. a, b qRT-PCR analysis of GATA2 in human LECs (a) and primary mouse LECs (b) grown on soft (0.2 kPa) or stiff (25 kPa) matrix. n = 3 experiments, mean ± s.e.m. p value, one-sample t-test. c Immunofluorescence of human LECs grown on stiff and soft matrix using antibodies against GATA2 (green) and VE-cadherin (red), and for DAPI to show nuclei (grey). LECs grown on soft matrix exhibit an overall higher expression of GATA2 as indicated by higher immunofluorescence intensity in both the nucleus and cytoplasm and have an elongated shape and a distorted nucleus. d Quantification of nuclear and cytoplasmic GATA2 protein in human LECs grown on soft (0.2 kPa) or stiff (25 kPa) matrix. Data represent mean pixel intensity (n = 8 images with 8–24 cells per image (soft), and n = 8 images with 21–37 cells per image (stiff) from 3 experiments) ± s.e.m. p value, unpaired Student’s t-test. Scale bars: 50 µm
Fig. 2 GATA2 regulation by matrix stiffness in LECs. a, b qRT-PCR analysis of GATA2 in human LECs (a) and primary mouse LECs (b) grown on soft (0.2 kPa) or stiff (25 kPa) matrix. n = 3 experiments, mean ± s.e.m. p value, one-sample t-test. c Immunofluorescence of human LECs grown on stiff and soft matrix using antibodies against GATA2 (green) and VE-cadherin (red), and for DAPI to show nuclei (grey). LECs grown on soft matrix exhibit an overall higher expression of GATA2 as indicated by higher immunofluorescence intensity in both the nucleus and cytoplasm and have an elongated shape and a distorted nucleus. d Quantification of nuclear and cytoplasmic GATA2 protein in human LECs grown on soft (0.2 kPa) or stiff (25 kPa) matrix. Data represent mean pixel intensity (n = 8 images with 8–24 cells per image (soft), and n = 8 images with 21–37 cells per image (stiff) from 3 experiments) ± s.e.m. p value, unpaired Student’s t-test. Scale bars: 50 µmCC BY · PubMed Central
Fig. 3 Defective migration of venous-derived LEC progenitors upon loss of endothelial Gata2 expression. a Relative expression levels of Gata2, the LEC markers Vegfr3 and Pdpn and the pan-endothelial marker Erg in ECs within the CV (Prox1-GFP+PDPN−) compared to LECs outside of the CV (Prox1-GFP+PDPN+). ECs were freshly isolated from E11 Prox1-GFP embryos (n = 3 independent samples with 4 pooled embryos in each, from two different litters). Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. b Immunofluorescence of transverse cryosections of E11 embryos using antibodies against GFP (green; Prox1-GFP), GATA2 (magenta) and VEGFR3 (red). Single channel images are shown. The IMARIS surface mask depicts in yellow the surface area used to extract GATA2 and VEGFR3 signal intensity. The surface mask was generated based on Prox1-GFP expression of VEGFR3+ LECs within and outside of the CV. c Quantification of GATA2 and VEGFR3 staining intensity in ECs within (n = 35) and outside (n = 37 measurements) of the CV. Data represent mean ± s.e.m. p value, unpaired Student’s t-test. d Schematic of the genetic constructs and analyzed embryonic stages. The time frames for pTD + PLLV (i.e. ‘jugular lymph sac’) and dermal lymphatic vessel formation are indicated. e Immunofluorescence of transverse vibratome sections of E12.5 embryos using antibodies against PROX1 (green) and Emcn (red; marker of venous EC). Single channel images for Emcn staining are shown. Note smaller jugular lymph sac (JLS) and the presence of PROX1+ Emcn− LECs (arrowhead) within the CV in the mutant embryo. f Maximum intensity projections of E12.5 embryos (sagittal view) stained whole-mount for indicated proteins and imaged using light sheet microscopy. Single channel images for PROX1 staining are shown. Arrowheads point to lymphovenous valves that are deformed in the mutant embryos. g E13.5 embryos (panels on the right) and whole-mount upper thoracic dorsal skin stained for Nrp2 (green) and Emcn (red). Nrp2+ dermal lymphatic vessels are absent in the mutant. Scale bars: 20 μm (b) 100 μm (e, f, g skins), 1 mm (g, embryos)
Fig. 3 Defective migration of venous-derived LEC progenitors upon loss of endothelial Gata2 expression. a Relative expression levels of Gata2, the LEC markers Vegfr3 and Pdpn and the pan-endothelial marker Erg in ECs within the CV (Prox1-GFP+PDPN−) compared to LECs outside of the CV (Prox1-GFP+PDPN+). ECs were freshly isolated from E11 Prox1-GFP embryos (n = 3 independent samples with 4 pooled embryos in each, from two different litters). Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. b Immunofluorescence of transverse cryosections of E11 embryos using antibodies against GFP (green; Prox1-GFP), GATA2 (magenta) and VEGFR3 (red). Single channel images are shown. The IMARIS surface mask depicts in yellow the surface area used to extract GATA2 and VEGFR3 signal intensity. The surface mask was generated based on Prox1-GFP expression of VEGFR3+ LECs within and outside of the CV. c Quantification of GATA2 and VEGFR3 staining intensity in ECs within (n = 35) and outside (n = 37 measurements) of the CV. Data represent mean ± s.e.m. p value, unpaired Student’s t-test. d Schematic of the genetic constructs and analyzed embryonic stages. The time frames for pTD + PLLV (i.e. ‘jugular lymph sac’) and dermal lymphatic vessel formation are indicated. e Immunofluorescence of transverse vibratome sections of E12.5 embryos using antibodies against PROX1 (green) and Emcn (red; marker of venous EC). Single channel images for Emcn staining are shown. Note smaller jugular lymph sac (JLS) and the presence of PROX1+ Emcn− LECs (arrowhead) within the CV in the mutant embryo. f Maximum intensity projections of E12.5 embryos (sagittal view) stained whole-mount for indicated proteins and imaged using light sheet microscopy. Single channel images for PROX1 staining are shown. Arrowheads point to lymphovenous valves that are deformed in the mutant embryos. g E13.5 embryos (panels on the right) and whole-mount upper thoracic dorsal skin stained for Nrp2 (green) and Emcn (red). Nrp2+ dermal lymphatic vessels are absent in the mutant. Scale bars: 20 μm (b) 100 μm (e, f, g skins), 1 mm (g, embryos)CC BY · PubMed Central
Fig. 4 GATA2 regulates a matrix stiffness-induced transcriptional program in the LECs. a Schematic overview of microarray gene expression analysis comparing Ctrl and GATA2 siRNA-treated human LECs grown on stiff (25 kPa) or soft (0.2 kPa) matrix. Number of genes regulated by matrix stiffness (n = 6 biological replicates) and the proportion of those showing GATA2-regulated expression (n = 2 biological replicates) are shown. b Selected TOP genes that are upregulated or downregulated on soft (0.2 kPa) in comparison to stiff (25 kPa) matrix and affected by GATA2 depletion. Heatmap color coding shows maximum for log2 fold change >1 or <−1. c Verification of microarray data in 2 additional independent experiments by qRT-PCR analysis shows the expected downregulation of markers of proliferation (CCNB1) and YAP/TAZ dependent mechanosignalling (CTGF, ANKRD1) in LECs grown on soft matrix. d Selected significantly enriched GO terms in LECs grown on soft matrix. The fold enrichment of upregulated (red bars) and downregulated (green bars) is shown. Genes associated with cell–matrix adhesion, cell migration and vascular development are upregulated on soft matrix, whereas genes associated with cell proliferation are downregulated. Notably, GO terms associated with cell migration, locomotion and motility (highlighted in red) are upregulated in a GATA2 dependent manner. e Verification of selected matrix stiffness regulated genes from the microarray expression analysis by qRT-PCR analysis in two independent experiments. Horizontal lines represent mean
Fig. 4 GATA2 regulates a matrix stiffness-induced transcriptional program in the LECs. a Schematic overview of microarray gene expression analysis comparing Ctrl and GATA2 siRNA-treated human LECs grown on stiff (25 kPa) or soft (0.2 kPa) matrix. Number of genes regulated by matrix stiffness (n = 6 biological replicates) and the proportion of those showing GATA2-regulated expression (n = 2 biological replicates) are shown. b Selected TOP genes that are upregulated or downregulated on soft (0.2 kPa) in comparison to stiff (25 kPa) matrix and affected by GATA2 depletion. Heatmap color coding shows maximum for log2 fold change >1 or <−1. c Verification of microarray data in 2 additional independent experiments by qRT-PCR analysis shows the expected downregulation of markers of proliferation (CCNB1) and YAP/TAZ dependent mechanosignalling (CTGF, ANKRD1) in LECs grown on soft matrix. d Selected significantly enriched GO terms in LECs grown on soft matrix. The fold enrichment of upregulated (red bars) and downregulated (green bars) is shown. Genes associated with cell–matrix adhesion, cell migration and vascular development are upregulated on soft matrix, whereas genes associated with cell proliferation are downregulated. Notably, GO terms associated with cell migration, locomotion and motility (highlighted in red) are upregulated in a GATA2 dependent manner. e Verification of selected matrix stiffness regulated genes from the microarray expression analysis by qRT-PCR analysis in two independent experiments. Horizontal lines represent meanCC BY · PubMed Central
Fig. 5 GATA2 regulates VEGFR3 expression and LEC responsiveness to VEGF-C. a Relative mRNA expression levels of Gata2, Vegfr3, Efnb2 and Fgfr3 in freshly isolated LECs from E15.5 Gata2 mutant (n = 4 or n = 5) and Cre− littermate control (n = 4) embryos. Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. b, c qRT-PCR analysis of GATA2 and VEGFR3 in control (Ctrl) and GATA2 siRNA-treated human LECs grown on soft (0.2 kPa) or stiff (25 kPa) matrix. n = 4 experiments, mean ± s.e.m. p value, one-sample t-test (for siCtrl stiff vs soft) or unpaired Student’s t-test. d Occupancy of chromatin at the FLT4 (encoding VEGFR3) locus as viewed in UCSC Human Genome Browser (http://genome.ucsc.edu/). GATA2 ChIP-seq profile demonstrating binding at the first intron of the FLT4 locus in human dermal LECs. Co-occupancy with H3K27Ac and sites of DNase hypersensitivity, both marks of active enhancer elements, are shown in ENCODE tracks (HUVEC, light blue peaks). e qRT-PCR and western blot analysis of Gata2 and Vegfr3 in control and 4-OHT treated (Gata2 deleted) primary mouse LECs. For qRT-PCR: n = 3 experiments, mean ± s.e.m. p value, one-sample t-test. Main band (125 kDa) quantification is shown in red. f Vehicle (Ctrl) and 4-OHT (KO) treated primary mouse LEC spheres in the absence (−) or presence of VEGF-C. Asterisks indicate sprouts. g Proportion of control (Ctrl) and Gata2 deficient (KO) LEC spheres forming sprouts in the absence (−) or presence of VEGF-C. n is indicated; p value, Fisher’s exact test. h Quantification of sprout length. Dots represent individual sprouts. Horizontal lines represent mean. n = 20–30 beads (from two independent experiments). p value, unpaired Student’s t-test
Fig. 5 GATA2 regulates VEGFR3 expression and LEC responsiveness to VEGF-C. a Relative mRNA expression levels of Gata2, Vegfr3, Efnb2 and Fgfr3 in freshly isolated LECs from E15.5 Gata2 mutant (n = 4 or n = 5) and Cre− littermate control (n = 4) embryos. Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. b, c qRT-PCR analysis of GATA2 and VEGFR3 in control (Ctrl) and GATA2 siRNA-treated human LECs grown on soft (0.2 kPa) or stiff (25 kPa) matrix. n = 4 experiments, mean ± s.e.m. p value, one-sample t-test (for siCtrl stiff vs soft) or unpaired Student’s t-test. d Occupancy of chromatin at the FLT4 (encoding VEGFR3) locus as viewed in UCSC Human Genome Browser (http://genome.ucsc.edu/). GATA2 ChIP-seq profile demonstrating binding at the first intron of the FLT4 locus in human dermal LECs. Co-occupancy with H3K27Ac and sites of DNase hypersensitivity, both marks of active enhancer elements, are shown in ENCODE tracks (HUVEC, light blue peaks). e qRT-PCR and western blot analysis of Gata2 and Vegfr3 in control and 4-OHT treated (Gata2 deleted) primary mouse LECs. For qRT-PCR: n = 3 experiments, mean ± s.e.m. p value, one-sample t-test. Main band (125 kDa) quantification is shown in red. f Vehicle (Ctrl) and 4-OHT (KO) treated primary mouse LEC spheres in the absence (−) or presence of VEGF-C. Asterisks indicate sprouts. g Proportion of control (Ctrl) and Gata2 deficient (KO) LEC spheres forming sprouts in the absence (−) or presence of VEGF-C. n is indicated; p value, Fisher’s exact test. h Quantification of sprout length. Dots represent individual sprouts. Horizontal lines represent mean. n = 20–30 beads (from two independent experiments). p value, unpaired Student’s t-testCC BY · PubMed Central
Fig. 6 LEC autonomous function of GATA2 in dermal lymphatic vessel sprouting and patterning. a Schematic of the genetic constructs, 4-OHT treatments (red arrowheads; red bars represent expected time frame of 4-OHT activity) and analyzed embryonic stages. The time frames for pTD + PLLV and dermal lymphatic vessel formation are indicated. b Whole-mount immunofluorescence of E15.5 and E17.5 upper thoracic dorsal skins using antibodies against VEGFR3 (green) and PROX1 (red), or VEGFR3 alone (single channel images on the right). Note reduced VEGFR3 levels in the mutant. c Whole-mount immunofluorescence of E17.5 upper thoracic dorsal skins using antibodies against PROX1 (green) and LYVE1 (red). Note developing valves consisting of clusters of highly PROX1 positive cells (arrowheads) that are present in control skin only. d–f Quantification of lymphatic vessel diameter (d), branch points (e) and the distance between contralateral sprouts (open midline; f) in E15.5 and E17.5 dorsal skin in Gata2 mutant (KO) and Cre– littermate control embryos. Horizontal lines represent mean (n = 16 (E15.5 Ctrl), n = 12 (E15.5 KO), n = 5 (E17.5 Ctrl), n = 11 (E17.5 KO)). p value, unpaired Student’s t-test. g Morphology of lymphatic vessel sprouts in E17.5 skin. h, i Quantification of filopodia numbers (h) and length (i) in E17.5 dermal lymphatic vessel sprouts. Horizontal lines represent mean (n = 9 (Ctrl) and n = 10 (KO) embryos), p value, unpaired Student’s t-test. j Quantification of LEC nuclei in E17.5 dorsal skin. Horizontal lines represent mean (n = 4 (Ctrl) and n = 7 (KO) embryos). p value, unpaired Student’s t-test. k Relative mRNA expression levels of the proliferation markers Mik67 and Ccnb1 in dermal LECs sorted from E15.5 Gata2 mutant (KO; n = 4 or n = 5) and Cre− littermate control (Ctrl; n = 4) embryos. Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. Scale bars: 100 μm (double-stained images in b, c), 50 μm (single channel images in b, g)
Fig. 6 LEC autonomous function of GATA2 in dermal lymphatic vessel sprouting and patterning. a Schematic of the genetic constructs, 4-OHT treatments (red arrowheads; red bars represent expected time frame of 4-OHT activity) and analyzed embryonic stages. The time frames for pTD + PLLV and dermal lymphatic vessel formation are indicated. b Whole-mount immunofluorescence of E15.5 and E17.5 upper thoracic dorsal skins using antibodies against VEGFR3 (green) and PROX1 (red), or VEGFR3 alone (single channel images on the right). Note reduced VEGFR3 levels in the mutant. c Whole-mount immunofluorescence of E17.5 upper thoracic dorsal skins using antibodies against PROX1 (green) and LYVE1 (red). Note developing valves consisting of clusters of highly PROX1 positive cells (arrowheads) that are present in control skin only. d–f Quantification of lymphatic vessel diameter (d), branch points (e) and the distance between contralateral sprouts (open midline; f) in E15.5 and E17.5 dorsal skin in Gata2 mutant (KO) and Cre– littermate control embryos. Horizontal lines represent mean (n = 16 (E15.5 Ctrl), n = 12 (E15.5 KO), n = 5 (E17.5 Ctrl), n = 11 (E17.5 KO)). p value, unpaired Student’s t-test. g Morphology of lymphatic vessel sprouts in E17.5 skin. h, i Quantification of filopodia numbers (h) and length (i) in E17.5 dermal lymphatic vessel sprouts. Horizontal lines represent mean (n = 9 (Ctrl) and n = 10 (KO) embryos), p value, unpaired Student’s t-test. j Quantification of LEC nuclei in E17.5 dorsal skin. Horizontal lines represent mean (n = 4 (Ctrl) and n = 7 (KO) embryos). p value, unpaired Student’s t-test. k Relative mRNA expression levels of the proliferation markers Mik67 and Ccnb1 in dermal LECs sorted from E15.5 Gata2 mutant (KO; n = 4 or n = 5) and Cre− littermate control (Ctrl; n = 4) embryos. Horizontal lines represent mean ± s.e.m. p value, unpaired Student’s t-test. Scale bars: 100 μm (double-stained images in b, c), 50 μm (single channel images in b, g)CC BY · PubMed Central
Fig. 7 Common and unique mechanoresponses during lymphatic vascular morphogenesis. a Area-proportional Venn diagrams of up- or downregulated genes in LECs grown on stiff or soft matrix (mimicking conditions of venous-derived LEC migration during the formation of first lymphatic vessels), and LECs subjected to static or oscillatory flow (mimicking initiation of valve formation14,16) conditions. Common TOP genes and selected GO terms are listed. b Schematic of venous-derived LEC migration out the CV. Exposure of venous-derived LECs to soft matrix induces GATA2-dependent increase in VEGFR3 expression and LEC migration. TOP regulated genes (red, up; green, down) are indicated
Fig. 7 Common and unique mechanoresponses during lymphatic vascular morphogenesis. a Area-proportional Venn diagrams of up- or downregulated genes in LECs grown on stiff or soft matrix (mimicking conditions of venous-derived LEC migration during the formation of first lymphatic vessels), and LECs subjected to static or oscillatory flow (mimicking initiation of valve formation14,16) conditions. Common TOP genes and selected GO terms are listed. b Schematic of venous-derived LEC migration out the CV. Exposure of venous-derived LECs to soft matrix induces GATA2-dependent increase in VEGFR3 expression and LEC migration. TOP regulated genes (red, up; green, down) are indicatedCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 74 references

Cited by

See all 169

Metadata

Authors
Frye, M., Taddei, A., Dierkes, C., Martinez-Corral, I., Fielden, M., Ortsäter, H., Kazenwadel, J., Calado, D. P., Ostergaard, P., Salminen, M., He, L., Harvey, N. L., Kiefer, F., & Mäkinen, T.
Affiliations
  • Uppsala University (SE)
  • The Francis Crick Institute (GB)
  • Max Planck Institute for Molecular Biomedicine (DE)
  • AlbaNova (SE)
  • South Australia Pathology (AU)
  • University of Helsinki (FI)
  • Tianjin Medical University General Hospital (CN)
  • University of Münster (DE)
Corresponding author
Mäkinen, Taija
Venue
Nature Communications
Published
2018-04-17
Volume
9
Issue
1
Pages
1511-1511
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2799633834
Cited by
169
References
74
Citations by year
2026: 14 · 2025: 21 · 2024: 15 · 2023: 28 · 2022: 20 · 2021: 33 · 2020: 20 · 2019: 14 · 2018: 4
FWCI
6.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Ludwig Institute for Cancer Research
  • Wellcome Trust (FC001057)
  • Francis Crick Institute (10057, FC001057, 10006)
  • Australian Government
  • Cancer Research UK (FC001057)
  • British Heart Foundation (SP/13/5/30288)
  • Deutsche Forschungsgemeinschaft (SFB 656, EXC-1003, SFB 629)
  • Cancerfonden (CAN 2013/387)
  • Vetenskapsrådet (542-2014-3535)
  • Uppsala Universitet
  • Science for Life Laboratory
  • Medical Research Council (MR/J008060/1, FC001057)
  • National Health and Medical Research Council (1061365)
  • H2020 European Research Council (646849)
Topics
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
  • Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
Keywords
extracellular matrix stiffness, lymphatic vessel formation, lymphangiogenesis, GATA2, lymphatic endothelial cells, VEGFR-3, VEGF-C, endothelial cell migration, cardinal vein, transcriptional regulation, vascular morphogenesis
MeSH terms
Animals, Cell Movement, Female, Humans, Male, Mice, Transgenic, Gene Expression Regulation, Developmental, Gene Expression Profiling, RNA, Small Interfering, Vascular Endothelial Growth Factor Receptor-3, Vascular Endothelial Growth Factor C, Lymphangiogenesis, Lymphatic Vessels, Endothelial Cells, GATA2 Transcription Factor, Mice, Gene Knockdown Techniques, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program. https://app.cochat.ai/papers/10.1038/s41467-018-03959-6
The paper
Frye, M., Taddei, A., Dierkes, C., Martinez-Corral, I., Fielden, M., Ortsäter, H., Kazenwadel, J., Calado, D. P., Ostergaard, P., Salminen, M., He, L., Harvey, N. L., Kiefer, F., & Mäkinen, T. (2018). Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program. Nature Communications. https://doi.org/10.1038/s41467-018-03959-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.